ADAPTIN BIO, INC. APTN
OTC · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2026-03-17
ADAPTIN BIO, INC. statistics & valuation
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Return on assets | -834.6% | -1304.2% | -22524.5% |
| Return on equity | 347.0% | 76.2% | 8.8% |
| Current ratio | 0.29 | 0.01 | 0.00 |
Source: SEC EDGAR filings · CIK 0001938571 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.